Raguraman, P.; Balachandran, A.A.; Chen, S.; Diermeier, S.D.; Veedu, R.N.
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation. Cancers 2021, 13, 5555.
https://doi.org/10.3390/cancers13215555
AMA Style
Raguraman P, Balachandran AA, Chen S, Diermeier SD, Veedu RN.
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation. Cancers. 2021; 13(21):5555.
https://doi.org/10.3390/cancers13215555
Chicago/Turabian Style
Raguraman, Prithi, Akilandeswari Ashwini Balachandran, Suxiang Chen, Sarah D. Diermeier, and Rakesh N. Veedu.
2021. "Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation" Cancers 13, no. 21: 5555.
https://doi.org/10.3390/cancers13215555
APA Style
Raguraman, P., Balachandran, A. A., Chen, S., Diermeier, S. D., & Veedu, R. N.
(2021). Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation. Cancers, 13(21), 5555.
https://doi.org/10.3390/cancers13215555